Vertaling van "al use of antioxidant " (Frans → Nederlands) :

Vivekananthan DP, Penn MS, Sapp SK et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.
DOI: 10.1002/14651858.CD000254.pub3. Vivekananthan DP, Penn MS, Sapp SK et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.

- Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial).
- Lei LC, Chen O, Aldini G, Johnson E, Rasmussen H, Yasukazu Y et al. Supplementation with lutein or lutein plus green tea extracts does not change ocidative stress in adequately nourished older adults. J Nutr Biochem 2009, in press

Van Leeuwen R, Boekhoorn S et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 2005; 24:3101-7.
Cugati S, Mitchell Pet al. Cataract surgery and the 10-year incidence of age-related maculopathy: the Blue Mountains Eye Study.

10. Hercberg S, Galan P, Preziosi P et al. The SU.VI. MAX Study: : a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals.
10.Hercberg S, Galan P, Preziosi P et al. The SU.VI. MAX Study: : a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals.

Analyse de: Bjelakovic G, Nikolova D, Gluud LL et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.
Bespreking van: Bjelakovic G, Nikolova D, Gluud LL et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.

14. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers.
14.Bjelakovic G, Nikolova D, Simonetti RG et al. Antioxidant supplements for preventing gastrointestinal cancers.

17. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.
17.Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

Dans un même ordre d’idée, l'étude LAST (Lutein Antioxidant Supplementation Trial) qui a été une des premières lancée dans ce domaine chez des patients atteints de DMLA utilisait un complément alimentaire contenant 10 mg de lutéine (Richer et al., 2004).
In eenzelfde gedachtegang maakte de LAST studie (Lutein Antioxidant Supplementation Trial), een van de eerste studies gestart in dat domein bij patiënten met LMD, gebruik van een voedingssupplement dat 10 mg luteïne bevatte (Richer et al., 2004).

33. Yaffe K , Clemons TE, McBee WL et al. Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial.
33.Yaffe K , Clemons TE, McBee WL et al. Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial.

Mention indiquant qu'un filtre de leucoréduction ne doit pas être utilisé Mention " For Autologous Use Only" (si applicable) OU Mention " For Use By Intended Recipient Only" (si receveur allogénique)
Vermelding dat geen leucoreductiefilter moet worden gebruikt Vermelding “For Autologous Use Only" (indien van toepassing) OF Vermelding " For Use By Intended recipient Only" (indien voor allogene ontvanger) Vermelding “For Nonclinical Use Only” (indien van toepassing)